… -Long-term safety and efficacy of delgocitinib cream for up to 36 weeks in adults with chronic hand eczema: results of the phase 3 open-label extension DELTA-3 trial
1. 系统已在2026-03-06 10:18:14对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
M Gooderham, S Molin, R Bissonnette…
British Journal of …, 2024
academic.oup.com
… adults with moderate to severe CHE in the randomized, double-blind, vehicle-controlled
DELTA-2 trial (2… applications of delgocitinib cream in patients with moderate to severe CHE. …

